Download PDF
Exp Clin Endocrinol Diabetes 2003; 111(6): 351-357
DOI: 10.1055/s-2003-42726
Article

J. A. Barth Verlag in Georg Thieme Verlag Stuttgart · New York

The Connection between QT Dispersion and Autonomic Neuropathy in Patients with Type 2 Diabetes

K. Takebayashi 1 , R. Sugita 1 , K. Tayama 1 , Y. Aso 1 , Y. Takemura 1 , T. Inukai 1
  • 1Department of Medicine, Koshigaya Hospital, Dokkyo University School of Medicine, Koshigaya, Japan
Further Information

Publication History

Received: May 3, 2002 First decision: September 29, 2002

Accepted: March 13, 2003

Publication Date:
01 October 2003 (online)

Also available at
    Permissions and Reprints

Abstract

It is controversial whether an increase in the QT dispersion (QTd) on the electrocardiogram (ECG) reflects cardiac autonomic neuropathy in diabetic patients. In the current study, the QTd was compared in 60 type 2 diabetic patients and in 30 healthy subjects, and its association with autonomic neuropathy in diabetic patients was investigated. An increased QTd was found in diabetic patients, compared to healthy subjects. The QTd had significant negative associations with the log of the low and high frequency power (log LF and HF, respectively) of the power spectral analyses (PSA) of heart rate variations and the systolic blood response during standing (Δ BP). There was no significant difference in the QTd between patients with and without sympathetic skin response (SSR), reflecting peripheral sympathetic function. A significant positive correlation was also found between QTd and the systolic blood pressure (SBP). On the other hand, there was no correlation between QTd and serum total cholesterol (TC), triglycerides (TG), fasting plasma glucose (FPG), hemoglobin (Hb) A1C concentrations or body mass index (BMI). By multiple regression analysis, the log HF, which reflects cardiac parasympathetic function, and the SBP alone were significantly associated with QTd as the dependent variable. The Δ BP and log LF, which partially reflect sympathetic nerve function, had no significant associations with QTd. These findings suggest that QTd reflects cardiac autonomic neuropathy (relative parasympathetic neuropathy) and that the QTd is also influenced by SBP, independent of autonomic neuro-function.

Key words

QT dispersion - autonomic neuropathy - type 2 diabetes

References

  • 1 Ali A, Malik F S, Dinshaw H, Jenkins J S, Collins T, White C J, Ramee S R. Reduction in QT dispersion with rheolytic thrombectomy in acute myocardial infarction: evidence of electrical stability with reperfusion therapy.  Catheter Cardiovasc Interv. 2001;  52 56-58
    PubMedGoogle Scholar
  • 2 Arildsen H, May O, Christiansen E H, Damsgaard E M. Increased QT dispersion in patients with insulin-dependent diabetes mellitus.  Int J Cardiol. 1999;  71 235-242
    CrossrefPubMedGoogle Scholar
  • 3 Cardoso C, Salles G, Bloch K, Deccache W, Siqueira-Filho A G. Clinical determinants of increased QT dispersion in patients with diabetes mellitus.  Int J Cardiol. 2001;  79 253-262
    CrossrefPubMedGoogle Scholar
  • 4 Clarkson P B, Naas A A, McMahon A, MacLeod C, Struthers A D, MacDonald T M. QT dispersion in essential hypertension.  Q J Med. 1995;  88 327-332
    PubMedGoogle Scholar
  • 5 Cowan J C, Yusoff D K, Moore M, Amos P A, Gold A E, Bourke J P, Transuphaswadikul S, Campbell R W. Importance of lead selection in QT interval measurement.  Am J Cardiol. 1988;  61 83-87
    CrossrefPubMedGoogle Scholar
  • 6 Davis M D. Natural evolution. L'Esperance FA Jr. Current Diagnosis and Management of Chorioretinal Diseases. St. Louis; CV Mosby 1974: 179-184
    Google Scholar
  • 7 Day C P, McComb J M, Campbell R W. QT dispersion: An indication of arrythmic risk in patients with long QT interval.  Br Heart J. 1990;  63 342-344
    PubMedGoogle Scholar
  • 8 Day C P, McComb J M, Matthews J, Campbell R W. Reduction in QT dispersion by sotalol following myocardial infarction.  Eur Heart J. 1991;  12 423-427
    PubMedGoogle Scholar
  • 9 Ewing D J, Campbell I W, Clarke B I. Heart rate changes in diabetes mellitus.  Lancet. 1981;  1 183-186
    PubMedGoogle Scholar
  • 10 Ewing D J, Neison J MM. QT interval length and diabetic autonomic neuropathy.  Diabetic Med. 1990;  7 23-26
    PubMedGoogle Scholar
  • 33 Festa A, D'Agostino Jr R, Rantaharju P, O'Leary D H, Rewers M, Mykkanen L, Haffner S M. Is QT interval a marker of subclinical atherosclerosis in non-diabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS). 
    Google Scholar
  • 11 Fujimoto J, Hirota M, Hata M, Kondo M, Shima K. Normal reference values and prediction equations of autonomic nerve functions based on variations in R-R interval in electrocardiographs.  J Japan Diab Soc. 1987;  30 167-173 , (article in Japanese, abstract in English)
    PubMedGoogle Scholar
  • 12 Gonin J M, Kadrofske M M, Schmaltz S, Bastyr B I, Vink A I. Corrected Q-T interval prolongation as diagnostic tool for assessment of cardiac autonomic neuropathy in diabetes mellitus.  Diabetes Care. 1990;  13 68-71
    PubMedGoogle Scholar
  • 13 Ichkhan K, Molnar J, Somberg J. Relation of left ventricular mass and QT dispersion in patient with systematic hypertension.  Am J Cardiol. 1997;  79 508-511
    CrossrefPubMedGoogle Scholar
  • 14 Kirvela M, Toivonen L, Lindgern L. Cardiac repolarization interval in end-stage diabetic and nondiabetic renal disease.  Clin Cardiol. 1997;  20 791-796
    PubMedGoogle Scholar
  • 15 Langen K J, Ziegler D, Weise F, Piolot R, Boy C, Hubinger A, Gries F A, Muller-Gartner H W. Evaluation of QT interval length, QT dispersion and myocardial m-iodobenzylguanidine uptake in insulin-dependent diabetic patients with and without autonomic neuropathy.  Clin Sci. 1997;  92 325-333
    PubMedGoogle Scholar
  • 16 Lipsitz L A. Orthostatic hypotension in the elderly.  N Eng J Med. 1989;  321 952-957
    PubMedGoogle Scholar
  • 17 Mayet J, Shahi M, McGrath K, Poulter N R, Sever P S, Foale R A, Thom S A. Left ventricular hypertrophy and QT dispersion in hypertension.  Hypertension. 1996;  28 791-796
    PubMedGoogle Scholar
  • 18 Ong J J, Sarma J S, Venkataraman K, Levin S R, Singh B N. Circadian rhythmicity of heart rate and QTc interval in diabetic autonomic neuropathy: Implications for the mechanism of sudden death.  Am Heart J. 1993;  125 744-752
    CrossrefPubMedGoogle Scholar
  • 19 Perkiomaki J S, Ikaheimo M J, Pikkujamsa S M, Rantala A, Lilja M, Kesaniemi Y A, Huikuri H V. Dispersion of the QT interval and autonomic modulation of heart rate in hypertensive men with and without left ventricular hypertrophy.  Hypertension. 1996;  28 16-21
    PubMedGoogle Scholar
  • 20 Rana B S, Band M M, Ogston S, Morris A D, Pringle S D, Struthers A D. Relation of QT interval dispersion to the number of different cardiac abnormalities in diabetes mellitus.  Am J Cardiol. 2002;  90 483-487
    CrossrefPubMedGoogle Scholar
  • 22 Sawicki P T, Kiwitt S, Bender R, Berger M. The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus.  J Intern Med. 1998;  243 49-56
    CrossrefPubMedGoogle Scholar
  • 23 Surawicz B. Will QT dispersion play a role in clinical decision-making?.  J Cardiovasc Electrophysiol. 1996;  7 777-784
    PubMedGoogle Scholar
  • 24 Takebayashi K, Aso Y, Sugita R, Takemura Y, Inukai T. Clinical usefulness of corrected QT intervals in diabetic autonomic neuropathy in patients with type 2 diabetes.  Diabetes Metab. 2002;  28 127-132
    PubMedGoogle Scholar
  • 25 Tomiyama H, Dova N, Fu Y, Kushiro T, Hisaki R, Shinozaki Y, Kanmatsuse K, Kajiwara N, Yoshida H, Hinohara S. Left ventricular geometric patterns and QT dispersion in borderline and mild hypertension. Their evolution and regression.  Am J Hypertens. 1998;  11 286-292
    CrossrefPubMedGoogle Scholar
  • 26 Veglio M, Chinaglia A, Borra M, Perin P C. Does abnormal QT interval prolongation reflect autonomic dysfunction in diabetic patients? QTc interval measure versus standardized tests in diabetic autonomic neuropathy.  Diabetic Med. 1995;  12 302-306
    PubMedGoogle Scholar
  • 27 Veglio M, Borra M, Stevens L K, Fuller J H, Perin and the Complications Study Group P CEURODIABIDDM. The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group.  Diabetologia. 1999;  42 68-75
    CrossrefPubMedGoogle Scholar
  • 28 Veglio M, Giunti S, Stevens L K, Fuller J H, Perin Complications Study Group P C;EURODIABIDDM. Prevalence of Q-T interval dispersion in type 1 diabetes and its relation with cardiac ischemia: the EURODIAB IDDM Complications Study Group.  Diabetes Care. 2002;  25 702-707
    PubMedGoogle Scholar
  • 29 Veglio M, Bruno G, Borra M, Macchia G, Bargero G, D'Errico N, Pagano G F, Cavallo-Perin P. Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort.  J Intern Med. 2002;  251 317-324
    CrossrefPubMedGoogle Scholar
  • 30 Wei K, Dorian P, Newman D, Langer A. Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus.  J Am Coll Cardiol. 1995;  26 859-863
    CrossrefPubMedGoogle Scholar
  • 31 Yesilbursa D, Serdar A, Aydinlar A. Effect of successful coronary angioplasty and stent implatation on QT dispersion.  Coron Artery Dis. 1999;  10 335-337
    PubMedGoogle Scholar
  • 32 Yokoshiki H, Kohya T, Tomita F, Tohse N, Nakaya H, Kanno M, Kitabatake A. Restoration of action potential duration and transient outward current by regression of left ventricular hypertrophy.  J Mol Cell Cardiol. 1997;  29 1331-1339
    CrossrefPubMedGoogle Scholar

M. D. Kohzo Takebayashi

Department of Medicine, Koshigaya Hospital
Dokkyo University School of Medicine

2-1-50, Minami-Koshigaya, Koshigaya

Saitama, 343-8555

Japan

Phone: +81 489651111

Fax: + 81 489 65 11 27

Email: takeb@gmail.plala.or.jp

      >